Chandler Glass

Chandler most recently worked in business development at Kyverna Therapeutics, a clinical stage biotechnology company developing cell therapies for autoimmune and neuromuscular disorders, where he focused on external collaborations and clinical site engagement for multiple clinical programs.  Before Kyverna, he worked in strategy at Cellarity, a transcriptomics based small molecule biotechnology company founded by Flagship Pioneering, where he was responsible for a broad range of corporate development and strategic initiatives.  Prior to Cellarity, he oversaw business development efforts at Salspera, a private clinical stage immunotherapy company.  Before Cellarity, he worked in corporate development for Eloxx Pharmaceuticals, a clinical stage biotechnology company specializing in rare diseases.

 

Chandler cofounded Aviator Biosciences, a private biotechnology company developing small molecules for cardiovascular disorders.  He is also a cofounder at Articulated Therapeutics, a private biotechnology company developing novel treatments for various fibrotic disorders.

 

Chandler received a BS and MS from Tufts University in Biomedical Engineering.